期刊文献+

HPLC法测定利福布汀原料药及胶囊中有关物质 被引量:1

Determination of Related Substances in Rifabutin Crude Drug and Capsules by HPLC
下载PDF
导出
摘要 目的:建立利福布汀原料药及胶囊中有关物质检查的方法。方法:采用高效液相色谱法。色谱柱为Agilent XDB-C8,流动相为乙腈-0.1 mol/L磷酸二氢钾溶液(pH 6.5±0.1)(50:50,V/V),流速为1.0 mL/min,检测波长为254 nm,柱温为30℃,进样量为20μL,供试品以流动相为溶剂制备成质量浓度为1.0 mg/mL的溶液。采用此新建立的方法与利福布汀原料药及胶囊质量标准中的现行方法(供试品溶液质量浓度为0.5 mg/mL,色谱柱为C18)分别进行系统适用性试验,并对利福布汀原料药及胶囊共6批样品进行有关物质检查(峰面积归一化法)。结果:利福布汀的检测质量浓度线性范围为0.8~16μg/mL(r=1.000 0),精密度、重复性和稳定性试验(12 h)的RSD均小于2.0%(n=6),检测限和定量限分别为0.025 4、0.085 2μg/mL。在系统适用性试验中,采用改进方法与现行方法,利福布汀峰与其前降解产物峰的分离度分别为7.50、3.47;在测定6批样品时,采用新方法检出的杂质个数较现行方法多1~5个,杂质总量高出0.19%~0.55%。结论:建立的新方法分离效果好,灵敏度高,可用于利福布汀原料药和胶囊有关物质的检查,更有助于控制药品质量。 OBJECTIVE:To establish a method for the determination of related substances in rifabutin crude drug and capsules by HPLC.METHODS:HPLC method was adopted.The determination was performed on Agilent XDB-C8 column with mobile phase consisted of acetonitrile-0.1 mol/L potassium dihydrogen phosphate solution(pH 6.5±0.1)(50:50,V/V)at the flow rate of1.0 mL/min.The detection wavelength was set at 25/4 nm,the column temperature was 30 ℃,and sample size was 20 μL.The mobile phase was used as solvent to prepare the sample solution with a mass concentration of 1.0 mg/mL.The system suitability test was performed by using newly established method and current method(mass concentration of sample solution 0.5 mg/mL,C18 column)stated in quality standard of rifabutin crude drug and capsules.Related substance test was conducted for 6 batches of rifabutin crude drug and capsule(peak area normalization method).RESULTS:The linear range of rifabutin was 0.8-16μg/mL(r=1.000 0),RSDs of precision,reproducibility and stability tests(12 h)were all lower than 2.0%(n=6);the limits of detection and quantification were 0.025 4,0.085 2 μg/mL.In system suitability test,by using new method and current method,separation degree of rifabutin peak and pre-degradation product peak were 7.50 and 3.47.When 6 batches of samples were determined,the number of impurities detected by this method was 1-5 more than that by the current method,and the total amount of impurities was0.19%-0.55% higher.CONCLUSIONS:Established new method is well-separated and sensitive,and can be used for the determination of related substance in rifabutin crude drug and capsules,which helps the quality control of drugs.
作者 易秋艳 崔学文 罗军 刘文跃 袁军 YI Qiuyan;CUI Xuewen;LUO Jun;LIU Wenyue;YUAN Jun(Microbial Center,Sichuan Institute for Food and Drug Control,Chengdu 611731,China;Quality Department,Sichuan Med-shine Pharmaceutical Co.Ltd.,Chengdu 611130,China)
出处 《中国药房》 CAS 北大核心 2019年第15期2047-2051,共5页 China Pharmacy
基金 国家科技重大专项课题(No.2017zx09101001)
关键词 利福布汀 有关物质 高效液相色谱法 原料药 胶囊 Rifabutin Related substances HPLC Crude drug Capsules
  • 相关文献

参考文献5

二级参考文献36

  • 1田治科,潘一斌.利福布汀胶囊溶出度测定[J].中国医药工业杂志,2004,35(10):619-620. 被引量:3
  • 2钟静,黄平,麦洁儿.新型抗结核病药物[J].中国热带医学,2005,5(2):399-400. 被引量:6
  • 3张侠,李敏,胡春梅,于俊,林霏申,茅惠娟,张向荣,吴玉君.利福布汀治疗耐多药肺结核临床观察[J].中国抗生素杂志,2006,31(4):223-224. 被引量:13
  • 4朱莉贞,傅瑜,初乃惠,叶志忠,肖和平,王巍,苑松林,张侠,罗永艾,马丽萍.利福类联合多种药物长疗程方案治疗耐多药肺结核[J].中华结核和呼吸杂志,2006,29(8):520-523. 被引量:55
  • 5Yau YL,Glenn DH,Barbara JC.Determination of rifabutin in human plasma by high-performance liquid chromatography with ltraviolet detection[J].Journal of Chromatography B,1996,676:125-130.
  • 6Giorgio G,Cleta Raffaella DP,Franca M,et al.Specihc high-performance liquid chromatography assay for determination of rifabutin plasma concentration following Extrelut column extraction[J].Journal of Chromatography B,1999,728:233-239.
  • 7谢惠安 阳国太 林善梓.现代结核病学[M].北京:人民卫生出版社,2001.422.
  • 8Egidio M, Lauretta M. Process for the preparation of rifa- mycin s derivatives: GB, 009744 [P]. 1979-06-20.
  • 9Leonardo M, Vittorio R, Carmine P. Rifamycin compoun- ds:US ,4017481[P].1977-04-12.
  • 10Glabski T, Zukowski E, Szypka Z, et al. Preparation of spiropiperidyl rifamycin antibiotics: PL, 168053[P]. 1995- 12-30.

共引文献21

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部